Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Inovio Pharmaceuticals, Inc. (INO) had Tangible Shareholders Equity of $6.07M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-19.68M |
|
-- |
|
-- |
|
$21.95M |
|
$-21.95M |
|
$2.27M |
|
$-19.68M |
|
$-19.68M |
|
$-19.68M |
|
$-19.68M |
|
$-19.68M |
|
$-19.68M |
|
$-21.95M |
|
$-21.21M |
|
69.10M |
|
69.10M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$39.44M |
|
$2.21M |
|
$10.34M |
|
$49.78M |
|
$37.92M |
|
-- |
|
$5.79M |
|
$43.71M |
|
$6.07M |
|
|
Tangible Shareholders Equity |
$6.07M |
$6.07M |
|
82.27M |
|
| Cash Flow Statement Financials | |
$-21.59M |
|
$2.64M |
|
$0.95M |
|
$44.27M |
|
$26.27M |
|
$-18.00M |
|
$0.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-324.37% |
|
-324.38% |
|
-39.54% |
|
-324.38% |
|
$0.07 |
|
$-0.31 |
|
$-0.31 |
|